
Polynovo (ASX: PNV) Disappoints Market With H1 FY 2025 results
Doctors love Polynovo’s Novosorb BTM and Novosorb MTX products, but the market hated its H1 FY 2025 results.
Doctors love Polynovo’s Novosorb BTM and Novosorb MTX products, but the market hated its H1 FY 2025 results.
It is not obviously cheap but it is obviously taking market share from its competitors.